Intervention

Placebo once daily

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Systemic Corticosteroids Avoidance Study in Severe Asthma PatientsNCT03629249 · 2018-12-13

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate AsthmaNCT02479412 · 2015-06-25

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPDNCT01039675 · 2010-01-01

Common conditions

Asthma2 Efficacy1 Pulmonary Disease, Chronic Obstructive1 Safety1

Leading sponsors

AstraZeneca1 GlaxoSmithKline1 Novartis Pharmaceuticals1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.